Literature DB >> 6488396

Studies on positive inotropic agents. I. Synthesis of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone and related compounds.

M Tominaga, E Yo, H Ogawa, S Yamashita, Y Yabuuchi, K Nakagawa.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6488396     DOI: 10.1248/cpb.32.2100

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


× No keyword cloud information.
  6 in total

1.  Effect of OPC-8490 on the membrane potentials and membrane currents of single guinea-pig myocytes.

Authors:  Y Momose; S Sasayama
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727

2.  The inhibitory effects of a positive inotropic quinolinone derivative, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), on bone-marrow progenitor cells and peripheral lymphocytes.

Authors:  F W Busch; A Tillmann; E W Becker; M Owsianowski; P A Berg
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

3.  A new cardiotonic agent, OPC-8212, elevates the myocardial oxygen consumption versus pressure-volume area (PVA) relation in a similar manner to catecholamines and calcium in canine hearts.

Authors:  S Futaki; T Nozawa; Y Yasumura; N Tanaka; H Suga
Journal:  Heart Vessels       Date:  1988       Impact factor: 2.037

4.  A placebo-controlled, randomized, double-blind study of OPC-8212 in patients with mild chronic heart failure. OPC-8212 Multicenter Research Group.

Authors: 
Journal:  Cardiovasc Drugs Ther       Date:  1990-04       Impact factor: 3.727

5.  Acute hemodynamic effects of a new inotropic agent, OPC-8212, on severe congestive heart failure.

Authors:  S Sasayama; M Inoue; H Asanoi; K Kodama; M Hori; T Sakurai; C Kawai
Journal:  Heart Vessels       Date:  1986       Impact factor: 2.037

6.  Synthesis of Pyrimidine Incorporated Piperazine Derivatives and their Antimicrobial Activity.

Authors:  K S Thriveni; B Padmashali; M B Siddesh; C Sandeep
Journal:  Indian J Pharm Sci       Date:  2014-07       Impact factor: 0.975

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.